{"id":26606,"date":"2009-01-27T15:11:57","date_gmt":"2009-01-27T15:11:57","guid":{"rendered":"https:\/\/patientbloodmanagement.org\/resources\/un-modelo-de-riesgo-de-anemia-grave-para-seleccionar-a-pacientes-con-cancer-para-la-profilaxis-primaria-con-epoetina-alfa-un-ensayo-prospectivo-controlado-y-aleatorizado-del-grupo-de-estudio-elypse\/"},"modified":"2024-06-06T15:32:39","modified_gmt":"2024-06-06T15:32:39","slug":"un-modelo-de-riesgo-de-anemia-grave-para-seleccionar-a-pacientes-con-cancer-para-la-profilaxis-primaria-con-epoetina-alfa-un-ensayo-prospectivo-controlado-y-aleatorizado-del-grupo-de-estudio-elypse","status":"publish","type":"resources","link":"https:\/\/patientbloodmanagement.org\/es\/resources\/un-modelo-de-riesgo-de-anemia-grave-para-seleccionar-a-pacientes-con-cancer-para-la-profilaxis-primaria-con-epoetina-alfa-un-ensayo-prospectivo-controlado-y-aleatorizado-del-grupo-de-estudio-elypse\/","title":{"rendered":"Un modelo de riesgo de anemia grave para seleccionar a pacientes con c\u00e1ncer para la profilaxis primaria con epoetina alfa: un ensayo prospectivo controlado y aleatorizado del grupo de estudio ELYPSE."},"content":{"rendered":"\n<p>Ray-Coquard I, Dussart S, Goillot C, Mayeur D, Debourdeau P, Ghesquieres H, Bachelot T, Le Cesne A, Anglaret B, Agostini C, Guastalla JP, Lancry L, Biron P, Desseigne F, Blay JY. Ann Oncol. 27 de enero de 2009.  [Epub ahead of print]<\/p>\n\n<p>Departamento de Oncolog\u00eda M\u00e9dica, Centro Integral del C\u00e1ncer L\u00e9on B\u00e9rard, Universidad de Lyon, y EA 4128 SIS Individu Sant\u00e9, Soci\u00e9t\u00e9<\/p>\n\n<p><a href=\"http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19174452\" target=\"_blank\" rel=\"noopener\">Resumen<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Ray-Coquard I, Dussart S, Goillot C, Mayeur D, Debourdeau P, Ghesquieres H, Bachelot T, Le Cesne A, Anglaret B, Agostini C, Guastalla JP, Lancry L, Biron P, Desseigne F, Blay JY. Ann Oncol. 27 de enero de 2009. [Epub ahead of print] Departamento de Oncolog\u00eda M\u00e9dica, Centro Integral del C\u00e1ncer L\u00e9on B\u00e9rard, Universidad de Lyon, <a href=\"https:\/\/patientbloodmanagement.org\/es\/resources\/un-modelo-de-riesgo-de-anemia-grave-para-seleccionar-a-pacientes-con-cancer-para-la-profilaxis-primaria-con-epoetina-alfa-un-ensayo-prospectivo-controlado-y-aleatorizado-del-grupo-de-estudio-elypse\/\">[&#8230;]<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"template":"","categories":[317],"tags":[],"class_list":["post-26606","resources","type-resources","status-publish","hentry","category-aplicacion-medica"],"acf":[],"_links":{"self":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources\/26606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/resources"}],"about":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/types\/resources"}],"author":[{"embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/users\/1"}],"wp:attachment":[{"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/media?parent=26606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/categories?post=26606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/patientbloodmanagement.org\/es\/wp-json\/wp\/v2\/tags?post=26606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}